The anti-leukemic efficacy of the third generation bisphosphonate ONO5920/YM529
Keywords: بیسفسفونات; YM529; ONO5920/YM529; BP; bisphosphonate; P-gp; P-glycoprotein; DNR; daunorubicin; PAM; pamidronate; ZOL; zoledronic acid; Ph+; philadelphia chromosome positive; Ara-C; cytarabine; MDR; multidrug-resistant; FCS; fetal calf serum; CML; chronic myelogeneous